Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072006 · ClinicalTrials.gov registry record
Top-Down Executive Control in Traumatic Brain Injury (TBI), PTSD and Combined
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 30
- Enrollment target
NCT01072006: Completed study, sponsored by VA Office of Research and Development.
NCT01072006 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01072006 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This research investigates processes involved with one being able to focus on relevant information and ignore non-relevant information in veterans with PTSD and those with a history of traumatic brain injury. In addition, this study evaluates whether there is an additive effect of having both PTSD and history of TBI on ability to focus attention and inhibit distracting information.
Primary Outcome
Functional magnetic resonance imaging (fMRI) is used to measure neural activity in participants during attentional task, specifically measured as a bold signal change from rest to attention task. We then calculate the correlation between the bold signal (fMRI) and the PTSD CheckList questionnaire score. (The bold signal from fMRI indirectly reflects the brain's use of glucose, the brain's main energy source.) Correlations are reflected in an R-value, and R-values can range from 0-1, where 0 mean
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-06-07 |
| Est. Completion | 2017-04-21 |
What the finished NCT01072006 record still lists
NCT01072006 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01072006 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01072006 about?
NCT01072006 is a clinical study titled "Top-Down Executive Control in Traumatic Brain Injury (TBI), PTSD and Combined". This research investigates processes involved with one being able to focus on relevant information and ignore non-relevant information in veterans with PTSD and those with a history of traumatic brain injury. In addition, this study evaluates whether there is an additive effect of having both PTSD a...
What is the current status of trial NCT01072006?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-06-07. Estimated completion is 2017-04-21.
Who is sponsoring clinical trial NCT01072006?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI